EPHEDRINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ephedrine hydrochloride and what is the scope of freedom to operate?
Ephedrine hydrochloride
is the generic ingredient in one branded drug marketed by Dr Reddys Labs Sa and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are twenty-two drug master file entries for ephedrine hydrochloride.
Summary for EPHEDRINE HYDROCHLORIDE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 22 |
| Raw Ingredient (Bulk) Api Vendors: | 39 |
| Clinical Trials: | 333 |
| What excipients (inactive ingredients) are in EPHEDRINE HYDROCHLORIDE? | EPHEDRINE HYDROCHLORIDE excipients list |
| DailyMed Link: | EPHEDRINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for EPHEDRINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mansoura University | PHASE4 |
| Qianfoshan Hospital | NA |
| Ain Shams University | NA |
Anatomical Therapeutic Chemical (ATC) Classes for EPHEDRINE HYDROCHLORIDE
US Patents and Regulatory Information for EPHEDRINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-002 | Jun 14, 2021 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-003 | Jun 14, 2021 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-004 | Dec 7, 2023 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
